SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-105074
Filing Date
2020-09-15
Accepted
2020-09-15 09:00:40
Documents
3
Period of Report
2020-09-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2030864d1_8k.htm 8-K 23305
2 EXHIBIT 10.1 tm2030864d1_ex10-1.htm EX-10.1 11614
3 EXHIBIT 10.2 tm2030864d1_ex10-2.htm EX-10.2 84035
  Complete submission text file 0001104659-20-105074.txt   120351
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

IRS No.: 481293684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33818 | Film No.: 201174811
SIC: 3845 Electromedical & Electrotherapeutic Apparatus